Theralase Technologies Inc. V.TLT

50 millions sharks shares...

[wildbird1]

Contrary to some, I am pleased with this new offering.

Let's see the facts.
1) A non-brokered private placement, give priority to "management & insiders plus accredited investors" on the offering.
2) The RCC(Research Capital Corporation) offering would have added approximately 50 millions shares to the total shares count.
3) This new offering will add approximately 12 millions shares to the total shares count.

My take on this offering is, it doesn't matter why the RCC offering was terminated( in the PressRelease no reasons given), a much smaller offering of just 12 millions shares in the hands of TLT insiders is much better than 50 millions sharks shares.

In short...
12 millions shares in the hands of TLT insiders versus 50 millions sharks shares in the hands of suspicious investors... This new offering is a plus for all TLT small & big investors.

[cashascars]

Good points wildbird, also  With the PP the new shares have a four month hold instead of tradeable shares from day with the LIFE financing. This alone will take the wieght off the share price and will remove a lot of sellers trying to get their money back from LIFE and just holding thier warrants. Another thing is the fact many were selling shares to buy into the LIFE but will now not

[enriquesuave]

My guess is that they are expecting BTD sooner, or have a JV or licensing deal close by and won't need to dilute as much.  Hence this new non broken PP.  just IMHO    

[stocksnbonds458]

Doest matter why it was canceled, I agree with Wildbird that this keeps dilution down and in a small amount of hands. Baby steps.....

[Oilminerdeluxe]

If the FDA suddenly wants 18 month confirmation from the fourteen CR patients, there must be a reason for that. And if they like what they see, that simply must have a positve impact on their decisions. It might speed things up even. I know it is hard to believe the words speed and TLT in the same sentence, but if FDA makes such a request, there must be something to follow that request if it is

[wildbird1]

I agree with Enriquesuave & Cashascars, there must be a very good reason why the RCC offering was terminated other than a lack of interest. What we know without a doubt is that TLT-Ruvidar is superior to anything out there. TLT-Ruvidar data are superior to Keytruda. TLT-Ruvidar data are superior to Adstiladrin. TLT-Ruvidar data are superior to N803+BCG. Note: N803+BCG has a very good CR%, but

[Oilminerdeluxe]

Interesting few days ahead. Not long until the next Q-update and new data.

[BudFoxx2020]

Willdbird how much do you get paid to post absolute nonsense every time.  Lololololol.  All the big promoters came out this weekend to calm the flocks.  A PP get canceled.  A PP get downsized.  And you get all the promoters coming out to tell you this is actually great.  Lololololololol.  Anyways this is as bad as it gets.  New lows coming soon this week

[reconsider]

These assumptions are plainly naive and discouraging when heard from some of the "trusted' bullboard voices. If they had BTD or a deal lined up, they would have announced the good news first, and afterwards dilute less at a higher price. Pretty basic for anyone here familiar with publicly traded companies. Why raise money for a whole year right before an event that could completely